Tide score was significantly lower in high-expressed ORC1 CRC samples than in low-expressed ones, which proposed a potentially greater response to immunotherapy in CRC samples with higher expression of ORC1 Fig. 20. This evidence concerns the gene ORC1 and colorectal carcinoma.